Healthline
March 25, 2025
Share on PinterestNew research suggests certain cardiovascular risk factors may impact women’s heart health more than men’s. Halfpoint Images/Getty Images New research indicates that certain cardiovascular […]
March 21, 2025
Share on PinterestNew research found that most of the popular content about ADHD on TikTok is medically inaccurate. Westend61/Getty Images A new analysis found that medical […]
March 20, 2025
Share on PinterestTwo new studies highlight the potential risks to heart health among young adults who use cannabis. Olena Bondarenko/Getty Images A retrospective study found that […]
March 19, 2025
Share on PinterestPeople who rely on compounded GLP-1 drugs say they might not be able to afford brand-name versions, which are often not covered by insurance. […]
Medscape
April 4, 2025
ORLANDO, Fla. — Beyond appropriate use criteria for Mohs surgery outlined by a multidisciplinary ad hoc task force in 2012, choice of treatment for superficial skin […]
April 4, 2025
Obesity specialist Carolynn Francavilla Brown, MD, was treating a woman in her late 40s, who was taking tirzepatide for several months — and successfully reaching her […]
April 4, 2025
Fatigue and frailty, two common comorbidities of inflammatory rheumatic diseases, often receive insufficient attention in rheumatologic care settings. Fatigue significantly reduces quality of life, while frailty […]
April 4, 2025
Esketamine combined with a serotonin-norepinephrine reuptake inhibitor (SNRI) for treatment-resistant depression (TRD) was linked to significantly lower rates of several adverse outcomes than esketamine plus a […]
FDA
March 27, 2025
On This Page Location Details The Universities at Shady Grove; Building II, 9630 Gudelsky Drive, Rockville, MD Event Details The In Vitro Permeation Test (IVPT) is […]
March 26, 2025
The Biologics Price Competition and Innovation Act (BPCIA), enacted March 23, 2010, was designed to create a regulatory pathway for the approval of biosimilars. It provides […]
March 26, 2025
FDA publishes a variety of lists and reports on generic drug application activities for public awareness, including: Content current as of: 03/26/2025 Regulated Product(s)
March 26, 2025
On March 26, 2025, the Food and Drug Administration approved cabozantinib (Cabometyx, Exelixis, Inc.) for adult and pediatric patients 12 years of age and older with […]
